Detalles de la búsqueda
1.
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.
Lancet
; 399(10328): 909-923, 2022 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35248186
2.
Efficacy and safety of golimumab in patients with non-radiographic axial spondyloarthritis: a withdrawal and retreatment study (GO-BACK).
Rheumatology (Oxford)
; 62(11): 3601-3609, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36919768
3.
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.
Ann Allergy Asthma Immunol
; 130(1): 60-66, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35569802
4.
Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis: results from open-label extension.
Rheumatology (Oxford)
; 61(2): 617-627, 2022 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33878154
5.
An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism.
Reprod Biol Endocrinol
; 15(1): 17, 2017 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28270212
6.
The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects.
Cytokine
; 72(2): 197-203, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25661195
7.
Treatment with the P2X3-Receptor Antagonist Gefapixant for Acute Cough in Induced Viral Upper Respiratory Tract Infection: A Phase 2a, Randomized, Placebo-Controlled Trial.
Pulm Ther
; 8(3): 297-310, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35969360
8.
Pharmacokinetics of Tildrakizumab (MK-3222), an Anti-IL-23 Monoclonal Antibody, After Intravenous or Subcutaneous Administration in Healthy Subjects.
Basic Clin Pharmacol Toxicol
; 123(3): 294-300, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29510001
9.
Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease.
Neurology
; 88(23): 2198-2206, 2017 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28490648
10.
Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study.
Breast Cancer Res
; 8(4): R44, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16859523
11.
The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer.
J Clin Oncol
; 22(1): 86-96, 2004 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14701769
12.
Multilevel modeling for the analysis of longitudinal blood pressure data in the Framingham Heart Study pedigrees.
BMC Genet
; 4 Suppl 1: S19, 2003 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-14975087
13.
Effect of aprepitant on the pharmacokinetics of the cyclin-dependent kinase inhibitor dinaciclib in patients with advanced malignancies.
Cancer Chemother Pharmacol
; 70(6): 891-8, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23053255
Resultados
1 -
13
de 13
1
Próxima >
>>